ImmunoGen (IMGN) ROE US GAAP (year values) |
||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | |||
| ROE, % | ? | -1 406% | 160.4% | -74.4% | -143.1% | -143.1% | 9.44% | |
| Changes by years, y/y, % | -1 942pp | +1 566pp | -235pp | -69pp | 0pp | |||
ImmunoGen. ROE, %
ImmunoGen. ROE, changes, pp
ImmunoGen (IMGN) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q2 | 2023Q4 | 2024Q1 | 2023Q3 | LTM ? | |||
| ROE, % | ? | -26.2% | -3.73% | -3.73% | 9.44% | 9.44% | 9.44% | |
| Changes by years, y/y, % | +90pp | +77pp | +141pp | +130pp | +125pp | |||
| Changes by quarters, q/q, % | +94pp | +22pp | 0pp | +13pp | 0pp | |||